GlaxoSmithKline Flovent HFA Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The CFC-free version of Flovent is approved for asthma in patients 12 years and older. The drug is the second HFA nasal steroid available.
You may also be interested in...
GlaxoSmithKline Discontinues Flovent Rotadisk
The company cites manufacturing issues and low sales in deciding to discontinue the fluticasone dosage form. The asthma product will continue to be available as inhalation aerosol.
GlaxoSmithKline Discontinues Flovent Rotadisk
The company cites manufacturing issues and low sales in deciding to discontinue the fluticasone dosage form. The asthma product will continue to be available as inhalation aerosol.
Albuterol MDI Essential Use Exemption To Be Discussed By Pulmonary Cmte.
FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet June 10 to consider the agency’s proposed rule removing the exemption for albuterol metered-dose inhalers containing chlorofluorocarbons.